56 citations
,
November 2007 in “Molecular and cellular endocrinology” This study identified enzymes responsible for regulating androgen action in the human prostate, suggesting that inhibiting AKR1C2 or RL-HSD may have therapeutic potential in androgen insufficiency or benign prostatic hyperplasia, respectively.
November 2025 in “Caderno Pedagógico” In this study, the combination of castor or cedar oils with high-frequency treatment was associated with the growth of new hair, improved hair density, and increased hair strand thickness among patients with androgenetic alopecia, although it did not significantly affect scalp oiliness.
In this study, a dual soft drug design strategy improved the AR antagonist candidate 39, showing potent AR antagonism and good safety in a mouse hair-growth model, with similar efficacy to pyrilutamide but faster response.
August 2025 in “Deleted Journal” This article provides an overview of herbal oils or extracts, particularly focusing on the benefits of Arwa oil, which combines various natural oils to nourish hair follicles and treat scalp inflammation, potentially addressing hair problems like hair loss and split ends.
December 2024 in “Journal of Applied Toxicology” This study evaluated the potential toxicity of oral dihydroartemisinin in SD rats, finding that female rats experienced greater toxic effects than males, particularly at higher doses, but these effects were reversible after a 4-week recovery period.
December 2022 in “Small methods” This study developed dissolving microneedles incorporating a new AR degrader for treating androgenetic alopecia, showing that a single application leads to superior hair regeneration compared to daily minoxidil, without systemic toxicity or androgen-related issues.
In a hair-growth mouse model, this study reported that the novel AR antagonist candidate 39, derived from structural optimization of 14-P1, achieved similar efficacy to pyrilutamide with faster response and maintained safety, demonstrating potent AR antagonism and favorable pharmacokinetics with lower systemic toxicity risk.
2 citations
,
July 2025 in “Scientific Reports” This study identified a novel Acinetobacter species, strain A1-4-2, with exceptional biodegradation abilities and low antibiotic resistance, found in diverse environments and potentially useful for ecological restoration by degrading organic pollutants.
March 2023 in “Agroland: The Agricultural Sciences Journal/Agroland : The Agricultural Sciences Journal” This review discusses the potential cosmeceutical benefits of Pontianak Aloe Vera, highlighting its use in products for skin and hair care, and reports no new results.
20 citations
,
September 2005 in “Endocrinology” This study identified novel selective androgen receptor modulators with enhanced in vivo pharmacological activity through structure-activity relationship analysis in castrated rats.
August 2025 in “Australasian Journal of Dermatology” This source presents an expert consensus framework for determining which Australian patients with alopecia areata should receive subsidized JAK inhibitor therapy, emphasizing the need for future research including patient perspectives to enhance criteria, ensure fair treatment access, and evaluate real-world outcomes.
2 citations
,
June 2018 in “Jurnal Penelitian dan Pengembangan Pertanian” This paper discusses the health benefits and cultivation of new beta-carotene-rich antioxidant maize varieties released by the Ministry of Agriculture, noting their potentially higher yields compared to ordinary corn.
July 2026 in “Advances in Therapy” This study found that clinicians treating alopecia areata prioritize JAK inhibitor treatments with higher efficacy and faster initial hair growth, regardless of dosing frequency, and preferred the treatment option with ritlecitinib 50-mg data the least among several blinded profiles.
June 2023 in “British journal of dermatology/British journal of dermatology, Supplement” This study observed that among UK alopecia areata patients seeking JAK inhibitor treatments before public funding, many sourced medication from abroad due to high costs, with variable response rates and significant reliance on social media for information on accessing treatments.
June 2025 in “Revista Foco” This review assessed randomised clinical trials on the efficacy and safety of topical and systemic JAK inhibitors for alopecia areata, finding significant hair coverage improvement with ritlecitinibe and baricitinibe, though prolonged treatment is often needed to maintain results.
October 2025 in “JEADV Clinical Practice” This paper creatively examines whether the name "Janus" in Janus kinase inhibitors foreshadows their dual role in the treatment of dermatological conditions, drawing parallels to the Roman god Janus's dual nature and influence over beginnings and transitions.
January 2011 in “Noordbrabants Historisch Jaarboek” This review discusses treatments for hirsutism, noting OCPs may help mild cases, while flutamide and spironolactone are associated with improvement for more severe cases, but reports no new research results.
1 citations
,
April 2025 in “International Journal of Morphology” In this study, Apricot Kernel Oil treatment in Wistar rats showed dose-dependent improvements for seborrheic dermatitis induced by DNFB, including reduced inflammation and oxidative stress and enhanced skin structure.
January 2017 in “Journal of Drug Research in Ayurvedic Sciences” This study conducted a detailed examination of Terminalia arjuna flowers, suggesting their potential use in establishing botanical standards for identification and standardization in Ayurvedic medicine.
11 citations
,
September 2010 in “PubMed” In this study, the researchers compared the pharmacokinetics and tissue distribution of dihydroartemisinin in nanostructured lipid carriers versus in solution, finding longer mean residence times and variable organ accumulation with the nanostructured lipid carriers.
January 1999 in “Journal of the European Academy of Dermatology and Venereology” RAPK is a rare skin disorder with pigmented spots, mainly on hands and feet, starting in youth.
June 2025 in “Jurnal Pemberdayaan Ekonomi dan Masyarakat” This study concluded that there is a significant market potential for rosemary oil-based hair care products in Indonesia, though consumer education and market penetration remain challenges.
March 2024 in “INDIAN JOURNAL OF APPLIED RESEARCH” In this case report, the authors describe using Polarity Analysis for selecting homeopathic remedies to better match patient symptoms in treating alopecia areata, offering a potential alternative to corticosteroids, which are associated with significant side effects.
March 2026 in “Dermatology Online Journal” Medicaid coverage for alopecia areata treatments is inconsistent and often limited.
In this study, the researchers reported that the optimized compound 39 demonstrated potent AR antagonism and favorable pharmacokinetics in a hair-growth mouse model, achieving similar efficacy to pyrilutamide with faster onset and preserved safety, offering promise for next-generation topical AR antagonist development.
10 citations
,
June 2022 in “Biomedicine & Pharmacotherapy” This review examines the molecular mechanisms by which the proapoptotic protein ARTS inhibits tumorigenesis and discusses prospects for developing drugs that mimic its function, with no new experimental results reported.
34 citations
,
January 2016 in “Analytical Chemistry” This study reports that a new DART-HRMS method can effectively analyze intact hair for drug use timelines, with cocaine detection aligning with forensic standards and identifying multiple drugs from high-resolution data.
October 2025 in “Open Repository of the University of Porto (University of Porto)”
April 2026 in “Inflammation and Regeneration” This study found that androgen inactivation pathways in scalp sebaceous glands change with age, specifically noting that AKR1C expression, including AKR1C4 previously thought liver-specific, declines with age and is sex dependent, which could impact hair follicle health during aging.